ACLARIS THERAPEUTICS INC (ACRS) Institutional Shareholders
ACLARIS THERAPEUTICS INC (ACRS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $627.55M in ACRS holdings during the latest filing period.
Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ACRS tracked by InsiderSet, reporting ownership valued at approximately $67.30M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $69.98M, representing an estimated gain of +3.97% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 62% of the total disclosed ACRS value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Bml Capital Management, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in ACLARIS THERAPEUTICS INC (ACRS).
This page ranks the largest institutional ACRS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
144
Total Reported Value
$627.55M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$67.30M
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
121
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 0.58% | 12,723,026 | $67,304,808 | $69,976,643 | +$2,671,835 | +3.97% | |
| Bml Capital Management, Llc | 36.18% | 11,975,000 | $63,347,750 | $65,862,500 | +$2,514,750 | +3.97% | |
| Blackrock, Inc. | 0.00% | 10,037,008 | $53,095,772 | $55,203,544 | +$2,107,772 | +3.97% | |
| Deep Track Capital, Lp | 0.73% | 9,345,000 | $49,435,050 | $51,397,500 | +$1,962,450 | +3.97% | |
| Vivo Capital, Llc | 3.23% | 6,694,637 | $35,414,630 | $36,820,504 | +$1,405,874 | +3.97% | |
| Vanguard Capital Management Llc | 0.00% | 5,817,866 | $30,776,511 | $31,998,263 | +$1,221,752 | +3.97% | |
| Frazier Life Sciences Management, L.P. | 0.57% | 4,925,374 | $26,055,228 | $27,089,557 | +$1,034,329 | +3.97% | |
| Rock Springs Capital Management Lp | 1.12% | 4,330,532 | $22,908,514 | $23,817,926 | +$909,412 | +3.97% | |
| Adage Capital Partners Gp, L.L.C. | 0.03% | 4,071,000 | $21,535,590 | $22,390,500 | +$854,910 | +3.97% | |
| Decheng Capital Llc | 2.92% | 4,041,736 | $21,380,783 | $22,229,548 | +$848,765 | +3.97% | |
| State Street Corp | 0.00% | 3,255,340 | $17,220,749 | $17,904,370 | +$683,621 | +3.97% | |
| Geode Capital Management, Llc | 0.00% | 3,190,058 | $16,879,468 | $17,545,319 | +$665,851 | +3.94% | |
| Braidwell Lp | 0.42% | 2,142,348 | $11,333,021 | $11,782,914 | +$449,893 | +3.97% | |
| Balyasny Asset Management L.P. | 0.02% | 2,023,470 | $10,704,156 | $11,129,085 | +$424,929 | +3.97% | |
| Silverarc Capital Management, Llc | 1.15% | 1,946,482 | $10,296,890 | $10,705,651 | +$408,761 | +3.97% | |
| Kalehua Capital Management Llc | 5.57% | 1,832,365 | $9,693,211 | $10,078,008 | +$384,797 | +3.97% | |
| Citadel Advisors Llc | 0.01% | 1,762,081 | $9,321,408 | $9,691,446 | +$370,038 | +3.97% | |
| Jones Hill Capital Lp | 1.98% | 1,759,492 | $9,307,713 | $9,677,206 | +$369,493 | +3.97% | |
| Acadian Asset Management Llc | 0.01% | 1,641,472 | $8,677,000 | $9,028,096 | +$351,096 | +4.05% | |
| Palo Alto Investors Lp | 1.18% | 1,613,430 | $8,535,045 | $8,873,865 | +$338,820 | +3.97% | |
| Woodline Partners Lp | 0.03% | 1,611,054 | $8,522,476 | $8,860,797 | +$338,321 | +3.97% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,465,735 | $7,753,738 | $8,061,543 | +$307,805 | +3.97% | |
| Panagora Asset Management Inc | 0.02% | 1,356,152 | $7,174,044 | $7,458,836 | +$284,792 | +3.97% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | 1,209,886 | $6,400,297 | $6,654,373 | +$254,076 | +3.97% | |
| Mpm Bioimpact Llc | 0.34% | 1,042,467 | $5,514,650 | $5,733,569 | +$218,919 | +3.97% | |
| Deutsche Bank Ag\ | 0.00% | 1,040,955 | $5,506,652 | $5,725,253 | +$218,601 | +3.97% | |
| Northern Trust Corp | 0.00% | 998,763 | $5,283,456 | $5,493,197 | +$209,741 | +3.97% | |
| Aldebaran Capital, Llc | 3.72% | 936,731 | $4,955,307 | $5,152,021 | +$196,714 | +3.97% | |
| Vanguard Fiduciary Trust Co | 0.00% | 907,173 | $4,798,945 | $4,989,452 | +$190,507 | +3.97% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 817,531 | $4,324,739 | $4,496,421 | +$171,682 | +3.97% |
| Three Bridge Wealth Advisors, Llc | 0.95% | 714,823 | $3,781,414 | $3,931,527 | +$150,113 | +3.97% | |
| Goldman Sachs Group Inc | 0.00% | 609,158 | $3,222,447 | $3,350,369 | +$127,922 | +3.97% | |
| Millennium Management Llc | 0.00% | 523,895 | $2,771,405 | $2,881,423 | +$110,018 | +3.97% | |
| Dimensional Fund Advisors Lp | 0.00% | 513,840 | $2,714,467 | $2,826,120 | +$111,653 | +4.11% | |
| Jpmorgan Chase & Co | 0.00% | 468,964 | $2,354,200 | $2,579,302 | +$225,102 | +9.56% | |
| Aisling Capital Management Lp | 0.49% | 434,455 | $2,298,267 | $2,389,503 | +$91,236 | +3.97% | |
| Bollard Group Llc | 0.07% | 431,631 | $2,283,000 | $2,373,971 | +$90,971 | +3.98% | |
| Orbimed Advisors Llc | 0.04% | 421,500 | $2,229,735 | $2,318,250 | +$88,515 | +3.97% | |
| D. E. Shaw & Co., Inc. | 0.00% | 414,499 | $2,192,700 | $2,279,745 | +$87,045 | +3.97% | |
| Susquehanna International Group, Llp | 0.00% | 412,549 | $2,182,384 | $2,269,020 | +$86,636 | +3.97% | |
| Tetragon Partners Gp Ltd | 0.34% | 400,000 | $2,116,000 | $2,200,000 | +$84,000 | +3.97% | |
| Russell Investments Group, Ltd. | 0.00% | 365,055 | $1,931,139 | $2,007,803 | +$76,664 | +3.97% | |
| Charles Schwab Investment Management Inc | 0.00% | 346,058 | $1,830,647 | $1,903,319 | +$72,672 | +3.97% | |
| Fmr Llc | 0.00% | 313,850 | $1,660,267 | $1,726,175 | +$65,908 | +3.97% | |
| Bank Of New York Mellon Corp | 0.00% | 282,599 | $1,494,949 | $1,554,295 | +$59,346 | +3.97% | |
| Nuveen, Llc | 0.00% | 278,404 | $1,472,758 | $1,531,222 | +$58,464 | +3.97% | |
| Raymond James Financial Inc | 0.00% | 275,611 | $1,457,982 | $1,515,861 | +$57,879 | +3.97% | |
| Wellington Management Group Llp | 0.00% | 267,498 | $1,415,064 | $1,471,239 | +$56,175 | +3.97% | |
| Superstring Capital Management Lp | 0.86% | 257,675 | $1,363,101 | $1,417,213 | +$54,112 | +3.97% | |
| Ubs Group Ag | 0.00% | 257,001 | $1,359,536 | $1,413,506 | +$53,970 | +3.97% |
Frequently asked questions about ACRS
Who owns the most ACRS stock?
The largest holders of ACRS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACLARIS THERAPEUTICS INC (ACRS).
Is ACRS widely held by superinvestors?
Many widely followed stocks like ACRS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ACRS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.